1887
Volume 2024, Issue 4
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Mycobacterium tuberculosis (TB) disease is a major global health problem affecting 10.6 million people worldwide, and India alone contributes 28% to this burden. Pancreatic TB is considered an extremely rare entity which closely mimics pancreatic carcinoma. However, while 87% of the total globally notified TB cases are from 30 high-burden countries mostly from Asia, about 45% of pancreatic TB cases are from developed countries. This suggests that the identified cases of pancreatic TB in developing counties are just the tip of iceberg, and many cases either remain undetected or wrongly diagnosed. The majority of the patients with pancreatic TB undergo extensive evaluation and frequently undergo major abdominal surgeries since pancreatic carcinoma is often considered as the most probable diagnosis before TB. Here, 2 cases of pancreatic TB managed separately at two different centers are described. Both cases presented with significant unintentional weight loss and poor glycemic control which is an unusual presentation for pancreatic TB. Imaging showed pancreatic mass lesions, and initially pancreatic carcinoma was considered by the treating physicians. Chromogranin A in both patients and tumor markers done in one of the patients were negative. Both the patients underwent Ga-68 DOTANOC PET/CT scan, and one of the patients even showed multiple DOTANOC avid lesions. Owing to contradictory biochemical and imaging findings, biopsy of the pancreatic mass was done which clinched the diagnosis of pancreatic TB. On starting standard anti-tubercular therapy (ATT), both patients showed clinical and radiological recovery with a significant regain of glycemic control. The clinical features, appropriate investigation including imaging and tissue biopsy, and treatment options are described in the article for better understanding of the disease. This may guide clinicians in early detection of pancreatic TB with least invasive diagnostic procedures.

© 2024 Varadaraj, Rai, Ghana, Maribashetti, Licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2024.54
2024-10-07
2025-07-15
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2024/4/qmj.2024.54.html?itemId=/content/journals/10.5339/qmj.2024.54&mimeType=html&fmt=ahah

References

  1. Training module on Extra-pulmonary Tuberculosis 2023. Ministry of Health and Family Welfare Government of India; 2023.
    [Google Scholar]
  2. World Health Organization. Global tuberculosis report. Geneva, Switzerland:World Health Organization; 2018.
    [Google Scholar]
  3. Chaudhary P, Bhadana U, Arora MP. Pancreatic tuberculosis. Indian J Surg. 2015Dec; 77:(6):517–24. https://doi.org/10.1007/s12262-015-1318-4
     [Google Scholar]
  4. Panic N, Maetzel H, Bulajic M, Radovanovic M, Löhr JM. Pancreatic tuberculosis: A systematic review of symptoms, diagnosis and treatment. United European Gastroenterol J. 2020May; 8:(4):396–402. https://doi.org/10.1177/2050640620902353
     [Google Scholar]
  5. Shabnam S, Mohammad BM, Mohammad TS, Amir HM. Pancreatic tuberculosis: An overview. J Pancreas (Online). 2015May20; 16:(3):232–8. https://doi.org/10.6092/1590-8577/2988
     [Google Scholar]
  6. Rana SS, Sharma V, Sampath S, Sharma R, Mittal BR, Bhasin DK. Vascular invasion does not discriminate between pancreatic tuberculosis and pancreatic malignancy: A case series. Ann Gastroenterol. 2014; 27:(4):395–8.
    [Google Scholar]
  7. Pombo F, DíazCandamio MJ, Rodriguez E, Pombo S. Pancreatic tuberculosis: CT findings. Abdom Imaging. 1998Jul–Aug; 23:(4):394–7. https://doi.org/10.1007/s002619900367
     [Google Scholar]
  8. Stridsberg M, Eriksson B, Oberg K, Janson ET. A comparison between three commercial kits for Chromogranin A measurements. J Endocrinol. 2003May; 177:(2):337–41. https://doi.org/10.1677/joe.0.1770337
     [Google Scholar]
  9. Gut P, Czarnywojtek A, Fischbach J, Baczyk M, Ziemnicka J, Wrotkowska E, et al.. Chromogranin A—unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls. Arch Med Sci. 2016Feb1; 12:(1):1–9. https://doi.org/10.5114/aoms.2016.57577
     [Google Scholar]
  10. Huang CT, Lo CY, Lee TH. Isolated peripancreatic tuberculous lymphadenopathy: A rare manifestation of abdominal tuberculosis mimicking pancreatic cystic neoplasm. J Dig Dis. 2013Feb; 14:(2):105–8. https://doi.org/10.1111/1751-2980.12011
     [Google Scholar]
  11. Singh D, Arya A, Agarwal A, Agarwal G, Ravina M, Gambhir S. Role of Ga-68 DOTANOC Positron Emission Tomography/Computed Tomography Scan in Clinical Management of Patients with Neuroendocrine Tumors and its Correlation with Conventional Imaging-Experience in a Tertiary Care Center in India. Indian J Nucl Med. 2022Jan–Mar; 37:(1):29–36. https://doi.org/10.4103/ijnm.ijnm_109_21
     [Google Scholar]
  12. Menda Y, O’Dorisio TM, Howe JR, Schultz M, Dillon JS, Dick D, et al.. Localization of unknown primary site with Ga-DOTANAOC PET/CT in patients with metastatic neuroendocrine tumor. J Nucl Med. 2017Jul; 58:(7):1054–7. https://doi.org/10.2967/jnumed.116.180984
     [Google Scholar]
  13. Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, et al.. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis. 2017Jan15; 64:(2):111–5. https://doi.org/10.1093/cid/ciw778
     [Google Scholar]
  14. Song TJ, Lee SS, Park DH, Lee TY, Lee SO, Seo DW, et al.. Yield of EUS-guided FNA on the diagnosis of pancreatic/peripancreatic tuberculosis. Gastrointest Endosc. 2009Mar; 69:(3 Pt 1):484–91. https://doi.org/10.1016/j.gie.2008.10.007
     [Google Scholar]
  15. Costache MI, Iordache S, Karstensen JG, Saftoiu A, Vilmann P. Endoscopic ultrasound-guided fine needle aspiration: From the past to the future. Endosc Ultrasound. 2013Apr; 2:(2):77–85. https://doi.org/10.4103/2303-9027.117691
     [Google Scholar]
  16. Chaudhary P. Hepatobiliary tuberculosis. Ann Gastroenterol. 2014; 27:(3):207–11.
    [Google Scholar]
  17. Nagar AM, Raut AA, Morani AC, Sanghvi DA, Desai CS, Thapar VB. Pancreatic tuberculosis: A clinical and imaging review of 32 cases. J Comput Assist Tomogr. 2009Jan–Feb; 33:(1):136–41. https://doi.org/10.1097/RCT.0b013e31816c82bc
     [Google Scholar]
  18. Sonthalia N, Ray S, Pal P, Saha A, Talukdar A. Fine needle aspiration diagnosis of isolated pancreatic tuberculosis: A case report. World J Clin Cases. 2013Aug16; 1:(5):181–6. https://doi.org/10.12998/wjcc.v1.i5.181
     [Google Scholar]
  19. Rao RN, Pandey R, Rana MK, Rai P, Gupta A. Pancreatic and peripancreatic tuberculosis presenting as hypoechoic mass and malignancy diagnosed by ultrasound-guided fine-needle aspiration cytology. J Cytol. 2013Apr; 30:(2):130–5. https://doi.org/10.4103/0970-9371.112658
     [Google Scholar]
  20. Malvezzi M, Carioli G, Bertuccio P, Rosso T, Boffetta P, Levi F, et al.. European cancer mortality predictions for the year 2016 with focus on leukaemias. Ann Oncol. 2016Apr; 27:(4):725–31. https://doi.org/10.1093/annonc/mdw022
     [Google Scholar]
  21. Bosetti C, Bertuccio P, Negri E, La Vecchia C. Zeegers MP, Boffetta P. Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog. 2012Jan; 51:(1):3–13. doi: 10.1002/mc.20785.
    [Google Scholar]
  22. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies. PLoS Med. 2008Jul15; 5:(7):e152. https://doi.org/10.1371/journal.pmed.0050152
     [Google Scholar]
  23. Stalenhoef JE, Alisjahbana B, Nelwan EJ, van der Ven-Jongekrijg J, Ottenhoff TH, van der Meer JW, et al.. The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis. 2008Feb; 27:(2):97–103. https://doi.org/10.1007/s10096-007-0395-0
     [Google Scholar]
  24. Patankar T, Prasad S, Laxminarayanan R. Diabetes mellitus: An uncommon manifestation of pancreatic tuberculosis. J Assoc Physicians India. 1999Sep; 47:(9):938–9.
    [Google Scholar]
  25. Pandita KK, Sarla Dogra S. Isolated pancreatic tuberculosis. Indian J Med Microbiol. 2009Jul–Sep; 27:(3):259–60. https://doi.org/10.4103/0255-0857.53212
     [Google Scholar]
  26. Rushing JL, Hanna CJ, Selecky PA. Pancreatitis as the presenting manifestation of miliary tuberculosis. West J Med. 1978Nov; 129:(5):432–6.
    [Google Scholar]
  27. Bhargava D. Abdominal tuberculosis: Current status. Apollo Med. 2007Dec; 4:(4):287–91. https://doi.org/10.1016/s0976-0016(11)60463-8
     [Google Scholar]
/content/journals/10.5339/qmj.2024.54
Loading
Two cases of pancreatic tuberculosis in immunocompetent individuals presenting as diabetes mellitus: An overview of clinical features, diagnosis and management
Qatar Medical Journal 2024, 54 (2024); https://doi.org/10.5339/qmj.2024.54
/content/journals/10.5339/qmj.2024.54
/content/journals/10.5339/qmj.2024.54
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): overview TB pancreas, Pancreatic diabetes and pancreatic tuberculosis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error